Trending: Bristol Myers Squibb Beats 4Q Sales Expectations
February 03 2023 - 2:24AM
Dow Jones News
10:29 ET -- Bristol Myers Squibb is one of the most mentioned
companies in the U.S. across all news items in the last 12 hours,
according to Factiva data. The pharmaceutical company reported
fourth-quarter sales of $11.41 billion, lower than $11.99 billion
in the prior-year period, but higher than expectations of $11.19
billion from analysts polled by FactSet. Profit came out at $2.02
billion, or 95 cents a share, below last year's $2.37 billion in
profit, or $1.07 a share, and analyst expectations of $2.26 billion
in profit or $0.82 a share. Earnings on an adjusted basis were
$1.82 a share, above analyst expectations of $1.73. Dow Jones &
Co. owns Factiva. (ada.hui@wsj.com)
(END) Dow Jones Newswires
February 02, 2023 10:44 ET (15:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024